To further study monocyte activation in vivo in patients with SLE, the percentage of total PBMCs that are monocytes (CD14+), the percentage of IL-6-producing monocytes in total monocytes, and plasma levels of sCD14 were tested in healthy female controls and female patients with SLE. This evidence concerns the gene CD14 and systemic lupus erythematosus.